#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Duchenne muscular dystrophy Glomerulonephritis rapidly progressive Aplastic anaemia Thrombotic microangiopathy Chronic inflammatory demyelinating polyradiculoneuropathy Hereditary optic atrophy Focal segmental glomerulosclerosis Atypical haemolytic uraemic syndrome Primitive neuroectodermal tumour Amyloidosis Alexander disease Short-bowel syndrome Pancreatic carcinoma metastatic Leukocyte adhesion deficiency Chronic graft versus host disease in liver More trials…

    Learn about Rare Diseases

    Piriformis syndrome – Basic Information Metachromatic leukodystrophy – Life with Disease Malignant fibrous histiocytoma – Basic Information Castleman’s disease Pituitary-dependent Cushing’s syndrome – Life with Disease Sjogren’s syndrome – Trials in Disease Retinoblastoma – Diagnostics Indolent systemic mastocytosis – Trials in Disease Glycogen storage disease type I – Life with Disease Sarcoidosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Apg777 Melphalan LYSERGIDE Lidocaine Hydrochloride Lysine Acetate Oxytocin Synthetic Foscarnet Betibeglogene Autotemcel Dexamethasone Ph. Eur. Ivermectin Naproxen Sodium Tisagenlecleucel APROTININ CEFTAROLINE FOSAMIL Voriconazole Glimepiride Sibeprenlimab Bi-1808 ETX-19477 Ziltivekimab More therapies…

    Learn about Your Condition

    Inflammatory bowel disease Thromboembolectomy Large cell lung cancer Chronic sinusitis Radiation skin injury Aortic valve disease Nasopharyngeal cancer Sciatica Renal impairment Renal cancer Peritoneal neoplasm Mental disorder Tendon injury Oesophageal carcinoma Small cell lung cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Myasthenia gravis

  • Study on the Effects of Inebilizumab for Adults with Myasthenia Gravis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Inebilizumab
    France Germany Italy Poland Spain

  • Study on the Safety and Effectiveness of Gefurulimab for Adults with Generalized Myasthenia Gravis

    Not recruiting

    3 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Gefurulimab
    Austria Denmark France Germany Italy The Netherlands +3

  • Study on Vimseltinib for Patients with Tenosynovial Giant Cell Tumor

    Not recruiting

    3 1
    Investigated Drugs:
    • Vimseltinib
    France Germany Italy The Netherlands Norway Poland +1

  • Study on the Effectiveness and Safety of Batoclimab for Adults with Generalized Myasthenia Gravis

    Not recruiting

    3 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Batoclimab
    Germany Hungary Italy Poland Romania Spain

  • Study on the Safety and Effectiveness of Zilucoplan Auto-Injector for Adults with Generalized Myasthenia Gravis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Zilucoplan Sodium
    Poland

  • Study on Cladribine for Treating Seropositive Myasthenia Gravis in Patients

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Cladribine
    Poland
Previous Page
1 … 5 6 7

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!